Image_2_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.tif
Background: Reduced HDACs levels have been reported in steroid resistant chronic obstructive pulmonary disease and bronchial asthma patients. P-glycoprotein (P-gp) over expression in peripheral blood mononuclear cells (PBMCs) has been reported in patients with steroid resistant nephrotic syndrome (NS). Whether and how HDACs and P-gp are linked with each other is not clear, especially in NS patients.
Aim: To evaluate mRNA expression of P-gp/MRP-1 and HDAC2 in PBMCs of steroid sensitive (SSNS) and steroid resistant nephrotic syndrome (SRNS) patients, and determine the relationship between expression of HDAC2 and P-gp/ MRP-1in NS patients.
Methods: Twenty subjects (10 in each group), SSNS (mean age 7.54 ± 3.5 years), and SRNS (mean age 8.43 ± 3.8 years) were recruited. mRNA expression of HDAC2 and P-gp/MRP-1 was studied by quantitative real time PCR. PBMCs were treated with Theophylline, 1 μM, and Trichostatin A, 0.8 μM, for 48 h for induction and suppression of HDAC2, respectively.
Results: At baseline, expression of P-gp (4.79 ± 0.10 vs. 2.13 ± 0.12, p < 0.0001) and MRP-1 (3.99 ± 0.08 vs. 1.99 ±0.11, p < 0.0001) on PBMCs were increased whereas, HDAC2 mRNA levels (2.97 ± 0.15 vs. 6.02 ± 0.13, p < 0.0001) were significantly decreased in SRNS as compared to that of SSNS patients. Compared to baseline, theophylline reduced mRNA expression of P-gp and MRP-1 (fold change 2.65 and 2.21, *p < 0.0001 in SRNS) (fold change 1.25, 1.24, *p < 0.0001 in SSNS), respectively. However, it increased the expression of HDAC2 (fold change 5.67, *p < 0.0001 in SRNS) (fold change 6.93, *p < 0.0001 in SSNS). Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, *p < 0.0001 in SRNS) and (fold change 3.49, 3.35, *p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, *p < 0.0001 in SRNS) (fold change 2.53, *p < 0.0001 in SSNS) patients.
Conclusion: Reduced HDAC2 and increased P-gp/MRP-1 activity may play a role in response to steroids in childhood NS. HDAC2 and P-gp/MRP-1 are in reciprocal relationship with each other.
History
References
- https://doi.org//10.1007/s12098-016-2142-y
- https://doi.org//10.1513/pats.200907-071DP
- https://doi.org//10.1016/j.jsbmb.2010.02.018
- https://doi.org//10.3390/ph3030725
- https://doi.org//10.1007/164_2016_62
- https://doi.org//10.1111/1756-185X.13386
- https://doi.org//10.1007/s00467-017-3677-5
- https://doi.org//10.1084/jem.20040416
- https://doi.org//10.2217/pgs.15.101
- https://doi.org//10.1016/j.placenta.2017.08.077
- https://doi.org//10.1016/S0140-6736(03)14184-0
- https://doi.org//10.1111/j.1442-200X.2008.02541.x
- https://doi.org//10.1542/peds.105.6.1242
- https://doi.org//10.1128/MCB.20.18.6891-6903.2000
- https://doi.org//10.1056/NEJMoa041892
- https://doi.org//10.1073/pnas.132556899
- https://doi.org//10.1084/jem.20050466
- https://doi.org//10.1093/ndt/gfr150
- https://doi.org//10.1158/1541-7786.MCR-08-0296
- https://doi.org//10.1016/j.bbrc.2008.02.013
- https://doi.org//10.1053/ajkd.2002.32769
- https://doi.org//10.1016/S0140-6736(18)30536-1
- https://doi.org//10.1016/j.jaci.2013.09.007
- https://doi.org//10.1016/j.cyto.2014.12.028
- https://doi.org//10.1111/1756-185X.12362
- https://doi.org//10.1073/pnas.0712363105
- https://doi.org//10.1007/s00467-018-3929-z
- https://doi.org//10.1007/BF00859637
- https://doi.org//10.1111/j.1749-6632.2003.tb05964.x
- https://doi.org//10.1038/sj.onc.1204323
- https://doi.org//10.18632/oncotarget.10488
- https://doi.org//10.1007/s00431-006-0256-3
- https://doi.org//10.1016/j.yexcr.2011.11.010
CC BY 4.0